Key Takeaways:
Neutrogena voluntarily recalled thousands of its makeup wipes due to potential bacterial contamination in a specific lot, though the origin of the contamination has not been identified. The recall affects 1,312 cases, totaling more than 15,000 packages across four states.
The recall applies specifically to the 50-count, 25-pack Makeup Remover Ultra-Soft Cleansing Towelettes, with the lot code 1835U6325A, limited to Georgia, Florida, South Carolina, and Texas. The recall was originally initiated in September after an internal investigation found traces of Pluralibacter gergoviae, a bacterium resistant to many cosmetic preservatives.
The Food and Drug Administration upgraded this to a Class II recall on October 3, meaning the product may cause “temporary or medically reversible adverse health consequences" or "the probability of serious adverse health consequences is remote." While the bacteria poses a low to moderate health risk, it can lead to illnesses like urinary tract infections (UTI), respiratory diseases, sepsis, and eye infections, especially for immunocompromised individuals.
According to Kenvue, Neutrogena's parent company, the product recall was done "out of an abundance of caution," and no other Neutrogena products have been affected.
This is not the first instance of Pluralibacter gergoviae contaminating other personal care products. Both Amika and Jergens (Kao USA) have had products recalled due to contamination.
Yet, this recall arrives at a time when Kenvue is struggling. For the second quarter, which ended on June 30, the company reported a 4.0% year-over-year decline in net sales, with organic sales falling 4.2%. This was attributed to fluctuations in inventory, softer seasonal demand, and global timing issues. As the owner of Tylenol, Kenvue has also been dealing with a public relations disaster sparked by President Trump and his administration falsely linking Tylenol to autism.
In response, Kenvue replaced its CEO and is considering streamlining its brand portfolio, exploring the divestiture of several of its smaller beauty brands, which have been “a drag on growth” for the company. This includes Clean & Clear, Maui Moisture, Neostrata, Bebe, and Dr.Ci:Labo.
“Kenvue has a strong portfolio of world-class, category-defining brands. We are actively focused on improving execution and performance, while advancing the comprehensive strategic alternatives review, to deliver our inherent value,” said Kirk Perry, Interim Chief Executive Officer.“
Thus, this recall adds to the pressures already facing Kenvue as it works to steady its performance and refocus its beauty portfolio.
